CCRT-induced PD-L1 expression in NSCLC after CCRT suggested that PD-L1 blockade in combination with CCRT is necessary to improve survival in NSCLC (Yoneda et al., 2019). Here, CD274 is linked to non-small cell lung carcinoma.